AUIC’s technology is a promising alternative to the more commonly known SVF (Stromal Vascular Fraction), utilizing Enzymatic Digestion for Cellular separation.
AUIC’s technology provides a cutting-edge procedure for liposuction providers in regenerative medicine, particularly as an alternative to stromal vascular fraction (SVF) from adipose tissue collected using conventional tumescent liposuction. Unlike traditional enzymatic digestion services, AUIC’s technology leverages ultrasonic cavitation to rapidly and efficiently isolate cellular components, offering several notable advantages.
How does AUIC’s technology work?
AUIC’s technology utilizes high-frequency ultrasonic waves that create cavitation bubbles within adipose tissue.
These bubbles rapidly expand and collapse, disrupting the extracellular matrix and liberating target cells, including mesenchymal stem cells, without the need for chemical enzymes. The process is swift, often taking minutes, and can be performed under controlled, sterile conditions. AUIC’s technology avoids these risks, resulting in higher viability and function of the extracted cells.
AUIC’s technology is the future
By offering an enzyme-free, more rapid, safe, and efficient method for separating cells from other molecules that may contain harmful donor-specific markers, AUIC’s technology is another step toward enhancing treatments and avoiding the possible risks of enzymes. Its ability to preserve cell integrity and function further amplifies potential benefits. AUIC’s technology represents a significant advancement over SVF and traditional enzymatic digestion in adipose-derived cell isolation. The efficiency and high safety profile make AUIC’s technology the future of regenerative cosmetics and therapeutics, ultimately improving patient outcomes through more accessible, safe, and reliable cellular therapies.
AKAN Biosciences
Passion. Innovative. Hardworking
Contact us for more information about programs, products and services